Catalent Inc. (NYSE: CTLT) started the day on Thursday, with a price decrease of -0.18% at $56.92, before settling in for the price of $57.02 at the close. Taking a more long-term approach, CTLT posted a 52-week range of $31.45-$67.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 12.64%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -47.08%. This publicly-traded company’s shares outstanding now amounts to $180.00 million, simultaneously with a float of $175.08 million. The organization now has a market capitalization sitting at $10.29 billion. At the time of writing, stock’s 50-day Moving Average stood at $56.75, while the 200-day Moving Average is $47.37.
Catalent Inc. (CTLT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – Specialty & Generic Industry. Catalent Inc.’s current insider ownership accounts for 3.13%, in contrast to 108.35% institutional ownership. According to the most recent insider trade that took place on Mar 15 ’24, this organization’s SVP, Quality & Reg. Affairs sold 387 shares at the rate of 56.20, making the entire transaction reach 21,749 in total value, affecting insider ownership by 29,506. Preceding that transaction, on Aug 31 ’23, Company’s Director bought 1,000 for 49.98, making the whole transaction’s value amount to 49,980. This particular insider is now the holder of 1,979 in total.
Catalent Inc. (CTLT) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2023, the organization reported -$0.24 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.02) by -$0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.63 per share during the current fiscal year.
Catalent Inc.’s EPS decrease for this current 12-month fiscal period is -47.08% and is forecasted to reach 1.48 in the upcoming year.
Catalent Inc. (NYSE: CTLT) Trading Performance Indicators
Let’s observe the current performance indicators for Catalent Inc. (CTLT). It’s Quick Ratio in the last reported quarter now stands at 1.73. The Stock has managed to achieve an average true range (ATR) of 0.55. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.50.
In the same vein, CTLT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -7.05, a figure that is expected to reach 0.20 in the next quarter, and analysts are predicting that it will be 1.48 at the market close of one year from today.
Technical Analysis of Catalent Inc. (CTLT)
If we take a close look at the recent performances of Catalent Inc. (NYSE: CTLT), its last 5-days Average volume was 1.05 million that shows plunge from its year to date volume of 2.67 million. During the previous 9 days, stock’s Stochastic %D was recorded 86.74% While, its Average True Range was 0.47.
Raw Stochastic average of Catalent Inc. (CTLT) in the period of the previous 100 days is set at 86.02%, which indicates a major rise in contrast to 80.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 6.06% that was lower than 33.08% volatility it exhibited in the past 100-days period.
